Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
transforming protein
of Rous sarcoma virus, p60src, was shown to be acylated at its amino terminus with the long-chain fatty acid myristic acid by isolation of a tryptic peptide with the following structure: myristylglycylserylseryllysine. The occurrence of this unusual posttranslational modification in the cyclic adenosine monophosphate-dependent
protein kinase
and in several
transforming protein
kinases of mammalian retroviruses suggests that myristylation of the amino terminal glycyl residue may be critical for the function of certain proteins related to cell transformation and growth control.
...
PMID:Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein. 391 76
The tyrosine-specific src kinase and the catalytic subunit of bovine heart adenosine 3',5'-
cyclic monophosphate-dependent protein kinase
phosphorylated glycerol when incubated with [gamma-32P]Mg-ATP. The product was detected by thin layer chromatography. The formation of glycerol phosphate by both enzymes was independent of the presence of a protein substrate (casein). The results show that glycerol phosphorylation is not a unique property of the src
transforming protein
. Because the product was only detected when high glycerol concentrations (approximately 0.1 M) were used, it is unlikely that either enzyme functions as a glycerol kinase in vivo.
...
PMID:Phosphorylation of glycerol by cAMP-dependent protein kinase: comparison with src kinase. 608 4
When analyzed from transformed cell lysates, pp60v-src, the product of the Rous sarcoma virus src gene, typically appears as a single polypeptide of 60,000 molecular weight, phosphorylated at two major sites, an amino-terminal region serine residue and carboxy-terminal region tyrosine residue. We describe here the identification of variant forms of pp60v-src present in transformed cell lysates that exhibited an altered electrophoretic mobility in sodium dodecyl sulfate-polyacrylamide gels. This change in migration appeared to be the result of some alteration in the amino-terminal portion of the molecule and paralleled the appearance of extensive amino-terminal region tyrosine phosphorylation on the pp60v-src molecule. These structural modifications were further correlated with a dramatic increase in the
protein kinase
-specific activity of pp60v-src. The detection of these variant forms of pp60v-src depended on the prior treatment of the transformed cell cultures with vanadium ions or the inclusion in the cell disruption buffer of Mg2+ or ATP-Mg2+. The implications is that modified, highly active forms of the pp60v-src protein exist in transformed cells, but are transient and rapidly converted to stable forms, possibly by specific dephosphorylation. We suggest that amino-terminal region tyrosine phosphorylation of pp60v-src, presumably the result of autophosphorylation, serves to greatly enhance src protein enzymatic activity, but that much of the regulation of this
transforming protein
's function may involve a phosphotyrosyl protein phosphatase.
...
PMID:Structurally and functionally modified forms of pp60v-src in Rous sarcoma virus-transformed cell lysates. 609 53
The
transforming protein
of Rous sarcoma virus (RSV) typically appears as a single phosphorylated polypeptide designated pp60v-src. pp60v-src possesses a
protein kinase
activity specific for tyrosine residues on select protein substrates. Treatment of RSV-transformed cells with vanadium ions resulted in the appearance of an electrophoretic variant of pp60v-src and was paralleled by a significant increase in the src kinase specific activity in purified enzyme preparations. Both the normal (standard) src kinase and the src kinase preparations obtained from vanadium-treated cells exhibited similar optimal activity profiles for MgCl2, KCl, and pH. Furthermore, their site specificities of phosphorylation of the substrates casein and vinculin were the same. The reaction kinetic profile of the standard src kinase showed a nonlinear pattern, while the vanadium enzyme exhibited conventional linear Michaelis-Menten kinetics. These results are discussed with respect to the possible functional regulation of pp60v-src activity by a vanadium-sensitive protein phosphatase activity.
...
PMID:Enzymatic characteristics of pp60v-src isolated from vanadium-treated transformed cells. 609 87
Infection of NIH/3T3 and Balb/c/3T3 fibroblastic cell lines by Abelson virus results in stable transformation in most cases. We have observed that certain rodent cell lines, including some Balb/c/3T3 sublines, do not maintain stable transformation following infection. Within three to four weeks of infection of these cell lines a large fraction of the cells is not recoverable upon serial passage and appear to be killed. The residual population of cells displays a flat, nontransformed phenotype. Concomitant with this reversion is the loss of the integrated provirus and loss of expression of the Abelson virus
transforming protein
. This loss of the integrated provirus is specific to transformation-competent viral strains. The effect of Abelson virus on these cells appears to be, in part, due to a lethal effect of the
transforming protein
on the cells. We have selectively isolated mutants of Abelson virus that stably transform these rodent cell lines without expressing a lethal effect. Analysis of the nucleic acid and protein structure of these mutant virus strains showed that the transforming proteins are shorter, having lost expression of the carboxy-terminal one third of the protein. We suspect that the carboxy-terminal portion of the wild-type Abelson protein may modulate the in vivo expression of the
protein kinase
activity and that this may cause the
transforming protein
to have a deleterious effect on certain cell lines.
...
PMID:Lethal effect of the Abelson murine leukemia virus transforming gene product. 610 Dec 2
We have derived a line of A431 human tumor cells infected with Rous sarcoma virus (RSV). The infected cells contain the RSV-
transforming protein
, pp60src, which has characteristic tyrosine specific
protein kinase
activity. As in other RSV-transformed cells, a 36,000-dalton protein is phosphorylated in RSV-infected A431 cells. Addition of epidermal growth factor (EGF) to the cells induces further phosphorylation of this protein. In contrast, this phosphoprotein is not detected in uninfected A431 cells, except when treated with EGF. Increased phosphorylation of the EGF receptor protein and of an 81,000-dalton cellular protein is dependent upon addition of EGF to the culture fluids, in both control and RSV-infected A431 cells. The results are discussed with reference to the similarities and differences between the tyrosine-specific protein kinases induced by RSV and activated by EGF.
...
PMID:Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus. 617 87
Chicken embryo tissues were examined for the expression of pp60c-src, the normal cellular homolog of the
transforming protein
of Rous sarcoma virus. Three assays, including a solid-phase radioimmunoassay, a competitive radioimmunoprecipitation assay, and an immune complex
protein kinase
assay, were employed. Elevated levels of pp60c-src were detected in lysates from several neural tissues, including brain, retina, and spinal ganglia. Other tissues contained 8- to 10-fold-lower levels of pp60c-src, levels comparable to those found in chicken embryo fibroblasts. Expression of pp60c-src in brain tissues was also shown to vary with the developmental stage of the embryo.
...
PMID:Neural tissues express high levels of the cellular src gene product pp60c-src. 619 23
Polyoma virus codes for three proteins involved in host cell transformation: the large, middle and small T antigens. Middle T antigen is a major
transforming protein
which is responsible for the induction of the phenotype of transformed cells and, without it, transformation does not occur (reviewed in refs 1-4). Middle T antigen alone can transform established cell lines, although large, and possibly small, T antigens are also required for the full expression of the phenotype of transformed cells in media with a low concentration of serum. A subfraction of middle T antigen is associated with a
protein kinase
activity which phosphorylates middle T antigen in vitro on tyrosine. There is a strong correlation between the level of this kinase activity and the degree of expression of the phenotype of transformed cells. We report here that epidermal growth factor (EGF) stimulates tyrosine phosphorylation of middle T antigen, suggesting the possibility that mitogenic growth factor(s) regulates this phosphorylation activity.
...
PMID:Enhancement of polyoma virus middle T antigen tyrosine phosphorylation by epidermal growth factor. 619 26
Using partially purified enzyme preparations, we show that incubation of the Rous sarcoma virus
transforming protein
kinase, pp60v-src, with Mg2+ and ATP at concentrations near or above the enzyme's Km for ATP resulted in a physical modification of the pp60v-src polypeptide. Under such conditions, a portion of pp60v-src was converted to a form that migrated more slowly in SDS-polyacrylamide gels than enzyme incubated without ATP or with low concentrations of ATP. Comparative tryptic peptide mapping of pp60v-src incubated with low and high levels of ATP revealed that more extensive tyrosine phosphorylation of the pp60v-src polypeptide occurred at the higher concentrations of ATP. This more extensive phosphorylation was characterized by the appearance of several new phosphorylated tyrosine residues on both the amino-terminal and carboxy-terminal portions of the pp60v-src molecule. The possible consequences of these modifications on the
protein kinase
activity of pp60v-src, and the functional regulation of retrovirus transforming proteins in general, are discussed.
...
PMID:Physical modification of purified Rous sarcoma virus pp60v-src protein after incubation with ATP/Mg2+. 619 31
We contrasted the
protein kinase
activities of pp60v-src, the
transforming protein
of Rous sarcoma virus, and its normal cellular homolog pp60c-src with respect to inhibition by P1,P4-di(adenosine-5')tetraphosphate by using the immune complex
protein kinase
assay. The concentration of P1,P4-di(adenosine-5')tetraphosphate required for 50% inhibition of pp60v-src kinase (1 microM) was found to be significantly lower than that required for inhibition of pp60c-src kinase (46 microM). Viral and cellular pp60src kinases differed to a lesser extent with respect to inhibition by adenosine-5'-tetraphosphate, di(guanosine-5')tetraphosphate, and ADP. No significant differences were found in the ATP Km values of pp60v-src (0.108 +/- 0.048 microM) and pp60c-src kinases (0.056 +/- 0.012 microM). These results demonstrate that the
protein kinase
activities of viral and cellular pp60src are functionally distinguishable, particularly on the basis of enhanced sensitivity of the viral enzyme to inhibition by P1,P4-di(adenosine-5')tetraphosphate. These functional differences are likely to be due to differences in the conformation of the active site and may be important for determining transformation potential.
...
PMID:Differential inhibition of cellular and viral pp60src kinase by P1,P4-di(adenosine-5')tetraphosphate. 619 14
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>